The Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research, commonly known as The Milstein Award, represents the pinnacle of scientific achievement in interferon and cytokine research. The Milstein Award is bestowed upon a leading biomedical research scientist who has made outstanding contributions to interferon and cytokine research, either in a basic or applied field. Many laureates have made seminal advancements that have enabled the successful treatment of disease or have the potential to lead to significant health benefits for humanity.
The Milstein family understood the importance of interferon research early on and established the Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research in 1988, two years after interferon was first approved for the treatment of hairy cell leukemia. Since that time, it has been widely recognized that interferons and the larger class of cytokines play critical roles in the development and progression of many major diseases including cancer, viral diseases such as hepatitis and influenza, and autoimmune disorders like multiple sclerosis and lupus. Nominations should be communicated to the President of the ISICR by June 1, 2011
Leonidas C. Platanias, M.D., Ph.D.
Deputy Director, Robert H. Lurie Comprehensive Cancer Center
Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology
Professor of Medicine
Northwestern University Medical School
303 East Superior Ave
Chicago, IL 60611